NCT01726374 Trial of 1 Cycle of Adjuvant BEP Chemotherapy in High Risk, Stage 1 Non-seminomatous Germ Cell Testis Tumours Status COMPLETED Phase PHASE3
NCT01719835 CHOP vs GEM-P in 1st Line Treatment of T-cell Lymphoma, Multicentre Phase II Study Status UNKNOWN Phase PHASE2
NCT01685190 A Study of Prostate and pelvIs Versus prOsTate Alone Treatment for Locally Advanced Prostate Cancer Status UNKNOWN Phase PHASE2
NCT01679119 Treatment of Patients With Diffuse Large B Cell Lymphoma Who Are Not Suitable for Anthracycline Containing Chemotherapy Status COMPLETED Phase PHASE2
NCT01668550 A Phase I Study of AZD0424 Alone and in Combination in Advanced Solid Tumours Status TERMINATED Phase PHASE1
NCT01650428 Bevacizumab And Combination Chemotherapy in Rectal Cancer Until Surgery Status COMPLETED Phase PHASE2
NCT01616238 A Study for Older Adults With Acute Lymphoblastic Leukaemia Status COMPLETED Phase PHASE2
NCT01608165 A Feasibility Study for a Multicentre Randomised Controlled Trial to Compare Surgery With Needle Ablation Techniques in People With Small Renal Masses (4cm) Status COMPLETED Phase NA
NCT01602588 A Randomised Trial Investigating the Additional Benefit of Hydroxychloroquine(HCQ)to Short Course Radiotherapy (SCRT) in Patients Aged 70 Years and Older With High Grade Gliomas (HGG) Status COMPLETED Phase PHASE2
NCT01598792 Safety Study of Recombinant Listeria Monocytogenes(Lm)Based Vaccine Virus Vaccine to Treat Oropharyngeal Cancer Status TERMINATED Phase PHASE1
NCT01590160 Ganetespib With Platinum, in Patients With Malignant Pleural Mesothelioma Status COMPLETED Phase PHASE1/PHASE2
NCT01586624 A Phase I Trial of Vandetanib (AZD6474) and Selumetinib (AZD6244) for Solid Tumours Including Non Small Cell Lung Cancer (VanSel-1) Status COMPLETED Phase PHASE1
NCT01566240 Induction Chemotherapy Plus Chemoradiation as First Line Treatment for Locally Advanced Cervical Cancer Status ACTIVE_NOT_RECRUITING Phase PHASE3
NCT01561911 A Phase I Study of the Chimeric Anti-CD40 Monoclonal Antibody ChiLob 7/4 to Treat Advanced Malignancies Refractory to Conventional Anti-cancer Treatment Status COMPLETED Phase PHASE1
NCT01556841 The Activity of TroVax® Versus Placebo in Relapsed Asymptomatic Ovarian Cancer Status COMPLETED Phase PHASE2
NCT01551459 A Phase II Study of Sunitinib Versus Dacarbazine in the Treatment of Patients With Metastatic Uveal Melanoma Status COMPLETED Phase PHASE2
NCT01460888 Radiotherapy & Olaparib in COmbination for Carcinoma of the Oesophagus Status UNKNOWN Phase PHASE1